| Description |
A labelled form of Ziprasidone which is an antagonist of both 5-HT and dopamine receptor and it has been studied to show effective antipsychotic activity. |
| Synonyms |
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl-d8]ethyl]-6=chloro-1,3-dihydro-2H-indol-2-one |
| IUPAC Name |
5-[2-[4-(1,2-benzothiazol-3-yl)-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one |
| Canonical SMILES |
C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54 |
| InChI |
InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)/i7D2,8D2,9D2,10D2 |
| InChI Key |
MVWVFYHBGMAFLY-UFBJYANTSA-N |
| Melting Point |
>206°C (dec.) |
| Purity |
97% (CP); 97% atom D |
| Solubility |
Soluble in DMSO, Methanol |
| Appearance |
Tan to Light Brown Solid |
| Application |
A labelled form of Ziprasidone which is an antagonist of both 5-HT and dopamine receptor and has been studied to show effective antipsychotic activity. |
| Shelf Life |
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
| Storage |
Store at -20°C |
